Mascoma Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $460K | Sell |
1,134
-102
| -8% | -$41.4K | 0.11% | 57 |
|
2025
Q1 | $615K | Buy |
1,236
+200
| +19% | +$99.5K | 0.15% | 48 |
|
2024
Q4 | $539K | Buy |
1,036
+14
| +1% | +$7.28K | 0.14% | 49 |
|
2024
Q3 | $632K | Hold |
1,022
| – | – | 0.16% | 46 |
|
2024
Q2 | $565K | Hold |
1,022
| – | – | 0.15% | 48 |
|
2024
Q1 | $594K | Hold |
1,022
| – | – | 0.17% | 46 |
|
2023
Q4 | $542K | Sell |
1,022
-33
| -3% | -$17.5K | 0.16% | 52 |
|
2023
Q3 | $534K | Buy |
1,055
+184
| +21% | +$93.1K | 0.17% | 54 |
|
2023
Q2 | $484K | Sell |
871
-171
| -16% | -$95K | 0.15% | 60 |
|
2023
Q1 | $578K | Sell |
1,042
-29
| -3% | -$16.1K | 0.17% | 59 |
|
2022
Q4 | $590K | Buy |
1,071
+3
| +0.3% | +$1.65K | 0.19% | 59 |
|
2022
Q3 | $542K | Sell |
1,068
-16
| -1% | -$8.12K | 0.19% | 63 |
|
2022
Q2 | $589K | Buy |
1,084
+48
| +5% | +$26.1K | 0.2% | 62 |
|
2022
Q1 | $612K | Buy |
1,036
+99
| +11% | +$58.5K | 0.19% | 66 |
|
2021
Q4 | $625K | Buy |
937
+94
| +11% | +$62.7K | 0.22% | 56 |
|
2021
Q3 | $482K | Hold |
843
| – | – | 0.19% | 60 |
|
2021
Q2 | $425K | Buy |
843
+16
| +2% | +$8.07K | 0.18% | 67 |
|
2021
Q1 | $377K | Buy |
+827
| New | +$377K | 0.16% | 72 |
|
2019
Q3 | – | Sell |
-125
| Closed | -$37K | – | 309 |
|
2019
Q2 | $37K | Sell |
125
-5
| -4% | -$1.48K | 0.02% | 178 |
|
2019
Q1 | $36K | Hold |
130
| – | – | 0.02% | 173 |
|
2018
Q4 | $29K | Hold |
130
| – | – | 0.02% | 176 |
|
2018
Q3 | $32K | Hold |
130
| – | – | 0.02% | 197 |
|
2018
Q2 | $27K | Buy |
130
+5
| +4% | +$1.04K | 0.02% | 201 |
|
2018
Q1 | $26K | Hold |
125
| – | – | 0.02% | 200 |
|
2017
Q4 | $27K | Sell |
125
-3
| -2% | -$648 | 0.02% | 191 |
|
2017
Q3 | $24K | Sell |
128
-3
| -2% | -$563 | 0.02% | 211 |
|
2017
Q2 | $23K | Buy |
131
+6
| +5% | +$1.05K | 0.02% | 225 |
|
2017
Q1 | $19K | Hold |
125
| – | – | 0.01% | 223 |
|
2016
Q4 | $18K | Buy |
+125
| New | +$18K | 0.01% | 229 |
|